What is the current Price Target for the ENDRA Life Sciences Inc. stock?

The average ENDRA Life Sciences Inc. target price is $38.76. This is 641.82% higher than the current stock price. The highest price target is 663.64%, the lowest is 634.55%. 3 Analysts have issued a price target ENDRA Life Sciences Inc. 2026 .

How high will the ENDRA Life Sciences Inc. stock rise?

No reliable answer can be given as to how high the ENDRA Life Sciences Inc. stock will rise. The performance of stocks, including the ENDRA Life Sciences Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the ENDRA Life Sciences Inc. stock today?

The performance of ENDRA Life Sciences Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the ENDRA Life Sciences Inc. stock fall?

The decline in ENDRA Life Sciences Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

ENDRA Life Sciences Inc. Forecast, price target & analysts

$5.23

11.44%

Nasdaq, Nov 07, 10:00 pm CET

ISIN

US29273B1044

Symbol

NDRA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Dividends Analysts Charts News Strategies

ENDRA Life Sciences Inc. Target price 2025 - Analyst rating & recommendation

ENDRA Life Sciences Inc. Classifications & Recommendation:

Buy

86%

Hold

14%

ENDRA Life Sciences Inc. Price Target

Target Price	$38.76
Price	$5.23
Potential	641.82% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target ENDRA Life Sciences Inc. 2026 . The average ENDRA Life Sciences Inc. target price is $38.76. This is 641.82% register free of charge higher than the current stock price. The highest price target is $39.90 663.64% register free of charge , the lowest is $38.38 634.55% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend ENDRA Life Sciences Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the ENDRA Life Sciences Inc. stock has an average upside potential 2026 of 641.82% register free of charge . Most analysts recommend the ENDRA Life Sciences Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-60.00	-7.63
	97.83%	87.28%
P/E		negative

3 Analysts have issued a ENDRA Life Sciences Inc. forecast for earnings per share. The average ENDRA Life Sciences Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-60.00	97.83%
2025	$-7.63 87.28% Unlock
2026	$-9.07 18.87% Unlock

Current	-0.43	56.40%
2025	-0.68 59.03% Unlock
2026	-0.58 14.71% Unlock

ENDRA Life Sciences Inc....

Current ENDRA Life Sciences Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Ascendiant Capital	Locked ➜ Locked	Locked	Sep 22 2025
Ascendiant Capital	Locked ➜ Locked	Locked	May 30 2025
Ascendiant Capital	Locked ➜ Locked	Locked	Apr 21 2025

Analyst Rating	Date
Locked Ascendiant Capital: Locked ➜ Locked	Sep 22 2025
Locked Ascendiant Capital: Locked ➜ Locked	May 30 2025
Locked Ascendiant Capital: Locked ➜ Locked	Apr 21 2025

Discover more stocks with a high price target

Novo Nordisk 60.25%

TUI 59.01%

Adidas 53.11%

Deutsche Telekom 45.39%

Meta Platforms (Facebook) 43.56%

Adyen 39.97%

BYD 38.89%

BioNTech SE - ADR 34.99%

Coinbase Global, Inc. 33.30%

Infineon 30.91%

Microsoft 29.34%

Netflix 28.46%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now